Andreoli, M. T., Pinnolis, M., Kieser, T., Sun, J., & Andreoli, C. M. (2015). Feasibility and efficacy of a mass switch from ranibizumab (Lucentis) to bevacizumab (Avastin) for treatment of neovascular age-related macular degeneration. Digital Journal of Ophthalmology, 21(3), 29–34. https://doi.org/10.5693/djo.01.2015.04.002